A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/04 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) C07K 14/00 (2006.01)
Patent
CA 2557654
The present invention relates to peptides derived from the proinflammatory cytokines, interleukin-1~, (IL1~) and tumor necrosis factor .alpha., (TNF.alpha.), and their use in human or veterinary therapy, such as to generally treat diseases linked to the overproduction of IL1~ or TNF.alpha. as well as acute or chronic inflammatory diseases, rheumatoid arthritis, septic shock, autoimmune diabetes, graft rejection in the host, etc.
L'invention concerne des peptides dérivés des cytokines proinflammatoires, de l'interleukine-1ß, (IL1ß), et du facteur de nécrose des tumeurs .alpha., (TNF.alpha.), et l'utilisation de ces peptides pour les traitements thérapeutiques de patients humains et animaux, notamment le traitement de maladies associées à un surproduction d'IL1ß ou de TNF.alpha., ainsi que des maladies inflammatoires aiguës ou chroniques, de la polyarthrite rhumatoïde, des chocs septiques, du diabète autoimmun, des rejets de greffes par l'hôte etc.
Bessis Natacha
Boissier Marie-Christophe
Zagury Jean-Francois
Borden Ladner Gervais Llp
Vaxconsulting
LandOfFree
Peptides of il1 beta and tnf alpha and method of treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides of il1 beta and tnf alpha and method of treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides of il1 beta and tnf alpha and method of treatment... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1700851